Natural History Museum of Denmark, Faculty of Science, University of Copenhagen, Sølvgade 83 S, DK1307 Copenhagen K, Denmark.
Comparative Plant & Fungal Biology, Royal Botanic Gardens, Kew, Surrey TW9 3AB, United Kingdom.
J Ethnopharmacol. 2015 Dec 24;176:90-101. doi: 10.1016/j.jep.2015.10.025. Epub 2015 Oct 17.
The genus Euphorbia (spurges, Euphorbiaceae) is the third largest genus of flowering plants, with almost 2000 species. Its exceptional diversity of growth forms and near-cosmopolitan distribution have attracted human interest since ancient times. For instance in Australia, topical application of latex of Euphorbia peplus L. is used as a home treatment for skin cancer and actinic keratosis. Its use in Australian folk medicine has inspired the release of the drug Picato® (ingenol mebutate), and further fostered interest in natural products and medicinal uses of Euphorbia in recent years.
To provide an indicative overview of medicinal uses of the genus Euphorbia driven by the recent interest in biologically active natural products from Euphorbia in drug discovery. We assess documented medicinal knowledge and value of the genus Euphorbia and the taxonomic distribution of this value.
We undertook an extensive survey of over 260 multidisciplinary publications on the online repository JSTOR using the search term "Euphorbia medicinal".
Medicinal uses were identified for >5% of the species in the genus, including descriptions of treatments for a variety of diseases. The most-cited medicinal uses around the world were treatments for digestive system disorders, skin ailments and, especially in the Southern hemisphere, infections. Consensus ratios indicated that the most-valued medicinal uses of Euphorbia species are in the treatment of digestive and respiratory complaints, inflammation and injuries, especially by members of Euphorbia subg. Chamaesyce.
The present study gives a first indicative overview of Euphorbia species used for health and wellbeing around the world. The exceptional diversity of the genus Euphorbia is not only represented by its growth forms but also by its diverse medicinal uses. Our results highlight the importance of research into medicinal uses of Euphorbia species and their importance as a source of natural products. Furthermore the medicinally highly valuable subgenus Chamaesyce was identified as chemically under-investigated, emphasizing the need for further studies investigating the chemical diversity to which the high medicinal value of Euphorbia subg. Chamaesyce can be attributed.
大戟属(大戟属,大戟科)是开花植物的第三大属,有近 2000 种。其生长形式的特殊多样性和近乎世界性的分布自古以来就引起了人类的兴趣。例如,在澳大利亚,将大戟属 Euphorbia peplus L. 的乳胶局部应用于皮肤癌和光化性角化病的家庭治疗。其在澳大利亚民间医学中的应用激发了 Picato®(ingenol mebutate)药物的释放,并进一步激发了近年来对大戟属天然产物和药用用途的兴趣。
提供一个大戟属药用用途的指示性概述,这是由近年来对药物发现中大戟属生物活性天然产物的兴趣所驱动的。我们评估了大戟属药用文献知识和价值以及这种价值的分类分布。
我们在 JSTOR 在线资源库上使用搜索词“Euphorbia medicinal”对超过 260 篇多学科出版物进行了广泛调查。
确定了该属 5%以上物种的药用用途,包括对各种疾病的治疗描述。全世界引用最多的药用用途是治疗消化系统疾病、皮肤病,特别是在南半球,还用于治疗感染。共识比率表明,大戟属物种最有价值的药用用途是治疗消化系统和呼吸系统疾病、炎症和损伤,特别是在大戟属亚属 Chamaesyce 中。
本研究首次对世界各地用于健康和福祉的大戟属物种进行了指示性概述。大戟属的非凡多样性不仅体现在其生长形式上,还体现在其多样化的药用用途上。我们的研究结果强调了研究大戟属物种药用用途及其作为天然产物来源的重要性。此外,药用价值极高的 Chamaesyce 亚属被确定为化学研究不足,强调需要进一步研究调查大戟属 Chamaesyce 亚属的化学多样性,这与其高药用价值有关。